Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Adma Biologics (ADMA) over the last 13 years, with Q3 2025 value amounting to 0.13.

  • Adma Biologics' Debt Ratio fell 5090.19% to 0.13 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13, marking a year-over-year decrease of 5090.19%. This contributed to the annual value of 0.15 for FY2024, which is 6268.78% down from last year.
  • Per Adma Biologics' latest filing, its Debt Ratio stood at 0.13 for Q3 2025, which was down 5090.19% from 0.13 recorded in Q2 2025.
  • In the past 5 years, Adma Biologics' Debt Ratio registered a high of 0.47 during Q2 2022, and its lowest value of 0.13 during Q3 2025.
  • For the 5-year period, Adma Biologics' Debt Ratio averaged around 0.34, with its median value being 0.4 (2021).
  • As far as peak fluctuations go, Adma Biologics' Debt Ratio soared by 1936.3% in 2022, and later tumbled by 6268.78% in 2024.
  • Quarter analysis of 5 years shows Adma Biologics' Debt Ratio stood at 0.34 in 2021, then grew by 19.36% to 0.41 in 2022, then fell by 3.21% to 0.4 in 2023, then tumbled by 62.69% to 0.15 in 2024, then decreased by 13.96% to 0.13 in 2025.
  • Its Debt Ratio was 0.13 in Q3 2025, compared to 0.13 in Q2 2025 and 0.14 in Q1 2025.